decisionhealth Newsletters, Part B News - 2016 Issue 2 (February)
FDA suggests vendors work with providers to boost medical cybersecurity
Subscribe or sign in to view the full article.
Article Overview
This article explains a draft FDA guidance on postmarket cybersecurity management for medical devices. It is relevant to device manufacturers, health care providers, compliance teams, and security-focused stakeholders who track how the FDA approaches vulnerability reporting, mitigation, and information sharing in networked medical devices. The discussion centers on general guidance themes, the regulatory context, and how the guidance may influence provider involvement in troubleshooting and monitoring.
Why This Topic Matters
Medical devices are increasingly connected, which raises cybersecurity concerns that can affect clinical performance and patient safety. Understanding the FDA’s draft guidance helps organizations anticipate postmarket responsibilities, collaboration expectations, and the broader compliance environment for networked medical equipment.
What You Will Learn
- The general purpose of the FDA draft guidance on medical device cybersecurity
- How postmarket vulnerability management is framed in the guidance
- Why collaboration between manufacturers and health care providers is emphasized
- How information sharing may support monitoring and troubleshooting of device-related cybersecurity concerns
- The relevance of the guidance to connected and networked medical devices
Who Should Read This
- Medical device manufacturers
- Health care providers
- Hospital compliance and risk teams
- Biomedical engineering and clinical engineering staff
- Health care IT and cybersecurity professionals
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com